0O9B.LSE Almirall

Healthcare Commercial Services & Supplies London Exchange
10.40 EUR
Close of Nov 3, 2026
9.88 13.80
Market cap
EUR 1.81B
P/E
-
P/B
-
ROE
-
Dividend yield
1.60%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2022.

Is 0O9B.LSE undervalued?

Graham number

The Graham number of Almirall cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Almirall fundamental analysis

No fundamental analysis for Almirall yet.

Almirall stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Almirall

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism, anti-infective for systemic use, cardiovascular system, dermatological, genito urinary syst…

Full company profile